SPS
CRBP icon

Susquehanna Portfolio Strategies’s Corbus Pharmaceuticals CRBP Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$713K Buy
+75,979
New +$719K 0.01% 618

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Susquehanna Portfolio Strategies's CRBP Position: Q2 2026 in Review

Susquehanna Portfolio Strategies opened a new position in Corbus Pharmaceuticals (CRBP) in Q2 2026: 75,979 shares worth $713K. The stake represents 0.01% of the portfolio and ranks #618 among its holdings.

107 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Susquehanna Portfolio Strategies held 75,979 shares of Corbus Pharmaceuticals worth $713K as of Q2 2026.
  • Corbus Pharmaceuticals was a new Susquehanna Portfolio Strategies position in Q2 2026.
  • Corbus Pharmaceuticals made up 0.01% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #618 holding.
  • 107 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.